Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;34(8):1094-1119.
doi: 10.1002/chir.23453. Epub 2022 Jun 8.

Advances and applications of chiral resolution in pharmaceutical field

Affiliations
Review

Advances and applications of chiral resolution in pharmaceutical field

Yan Teng et al. Chirality. 2022 Aug.

Abstract

The attention to chiral drugs has been raised to an unprecedented level as drug discovery and development strategies grow rapidly. However, separation of enantiomers is still a huge task, which leads to an increasing significance to equip a wider range of expertise in chiral separation science to meet the current and future challenges. In the last few decades, remarkable progress of chiral resolution has been achieved. This review summarizes and classifies chiral resolution methods in analytical scale and preparative scale systematically and comprehensively, including crystallization-based method, inclusion complexation, chromatographic separation, capillary electrophoresis, kinetic resolution, liquid-liquid extraction, membrane-based separation, and especially one bold new progress based on chiral-induced spin selectivity theory. The advances and recent applications will be presented in detail, in which the contents may bring more thinking to wide-ranging readers in various professional fields, from analytical chemistry, pharmaceutical chemistry, natural medicinal chemistry, to manufacturing of drug production.

Keywords: analytical scale separation; chiral resolution; chirality-induced spin selectivity; enantiomer; pharmaceutical field; preparative scale separation.

PubMed Disclaimer

References

REFERENCES

    1. Nguyen L, He H, Pham-Huy C. Chiral drugs: an overview. Int J Biomed Sci. 2006;2:85-100.
    1. Caner H, Groner E, Levy L, Agranat I. Trends in the development of chiral drugs. Drug Discov Today. 2004;9(3):105-110. doi:10.1016/S1359-6446(03)02904-0
    1. De Camp WH. Chiral drugs: the FDA perspective on manufacturing and control. J Pharm Biomed Anal. 1993;11(11):1167-1172. doi:10.1016/0731-7085(93)80100-F
    1. Norbert M, Pilar F, Wolfgang L. Separation of enantiomers: needs, challenges, perspectives. J Chromatogr a. 2001;906(1-2):3-33. doi:10.1016/S0021-9673(00)00532-X
    1. Lorenz H, Seidel-Morgenstern A. Processes to separate enantiomers. Angewandte Chemie International Ed in English. 2014;53(5):1218-1250. doi:10.1002/anie.201302823

Publication types

Substances

LinkOut - more resources